ANBT
NAGE

American National Bank & Trust’s Niagen Bioscience NAGE Stock Holding History

American National Bank & Trust’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.69K Hold
1,784
– – ﹤0.01% 536
2026
Q1 		$7.87K Hold
1,784
– – ﹤0.01% 503
2025
Q4 		$11.3K Hold
1,784
– – ﹤0.01% 496
2025
Q3 		$16.6K Sell
1,784
-662
-27% -$6.68K ﹤0.01% 478
2025
Q2 		$35.2K Hold
2,446
– – ﹤0.01% 419
2025
Q1 		$16.9K Hold
2,446
– – ﹤0.01% 441
2024
Q4 		$13K Buy
+2,446
New +$13.4K ﹤0.01% 425

Other funds holding NAGE

SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
AWM
Axxcess Wealth Management Carlsbad, California $6.28B AUM 24.26% 1-Year Est. Return
MGI
Miller Global Investments Dallas, Texas $121M AUM
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

American National Bank & Trust's NAGE Position: Q2 2026 in Review

American National Bank & Trust held its Niagen Bioscience (NAGE) position steady in Q2 2026 at 1,784 shares worth $5.69K. The position accounts for ﹤0.01% of the portfolio, ranked #536.

American National Bank & Trust first reported a position in NAGE in Q4 2024 and has held it in 7 quarters since. The position peaked at $35.2K in Q2 2025. 24 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • American National Bank & Trust held 1,784 shares of Niagen Bioscience worth $5.69K as of Q2 2026.
  • American National Bank & Trust left its Niagen Bioscience share count unchanged in Q2 2026.
  • Niagen Bioscience made up ﹤0.01% of American National Bank & Trust's portfolio in Q2 2026, its #536 holding.
  • American National Bank & Trust first reported a position in Niagen Bioscience in Q4 2024 and has held it in 7 quarters since.
  • American National Bank & Trust's Niagen Bioscience position peaked at $35.2K in Q2 2025.
  • 24 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on American National Bank & Trust's 13F filing for Q2 2026, filed 22 Jul 2026.